BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16880791)

  • 21. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
    Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F
    Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.
    Nitzsche B; Gloesenkamp C; Schrader M; Hoffmann B; Zengerling F; Balabanov S; Honecker F; Höpfner M
    Br J Cancer; 2012 Nov; 107(11):1853-63. PubMed ID: 23169338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
    Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
    Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.
    Selfe J; Goddard NC; McIntyre A; Taylor KR; Renshaw J; Popov SD; Thway K; Summersgill B; Huddart RA; Gilbert DC; Shipley JM
    J Pathol; 2018 Feb; 244(2):242-253. PubMed ID: 29160922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seladin-1 and testicular germ cell tumours: new insights into cisplatin responsiveness.
    Nuti F; Luciani P; Marinari E; Erdei E; Bak M; Deledda C; Rosati F; Mazzinghi B; Danza G; Stoop H; Looijenga LH; Peri A; Serio M; Krausz C
    J Pathol; 2009 Dec; 219(4):491-500. PubMed ID: 19844922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model.
    Jørgensen A; Blomberg Jensen M; Nielsen JE; Juul A; Rajpert-De Meyts E
    J Steroid Biochem Mol Biol; 2013 Jul; 136():238-46. PubMed ID: 23098692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours.
    di Pietro A; Vries EG; Gietema JA; Spierings DC; de Jong S
    Int J Biochem Cell Biol; 2005 Dec; 37(12):2437-56. PubMed ID: 16099193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MAD2-induced sensitization to vincristine is associated with mitotic arrest and Raf/Bcl-2 phosphorylation in nasopharyngeal carcinoma cells.
    Wang X; Jin DY; Wong HL; Feng H; Wong YC; Tsao SW
    Oncogene; 2003 Jan; 22(1):109-16. PubMed ID: 12527913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2.
    Ko JC; Su YJ; Lin ST; Jhan JY; Ciou SC; Cheng CM; Chiu YF; Kuo YH; Tsai MS; Lin YW
    Lung Cancer; 2010 Aug; 69(2):155-64. PubMed ID: 19962780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
    Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T
    Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MAD2DeltaC induces aneuploidy and promotes anchorage-independent growth in human prostate epithelial cells.
    To-Ho KW; Cheung HW; Ling MT; Wong YC; Wang X
    Oncogene; 2008 Jan; 27(3):347-57. PubMed ID: 17621272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
    Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
    J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of MEK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis.
    Jiang CC; Chen LH; Gillespie S; Wang YF; Kiejda KA; Zhang XD; Hersey P
    Cancer Res; 2007 Oct; 67(20):9750-61. PubMed ID: 17942905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells.
    Ko JC; Tsai MS; Chiu YF; Weng SH; Kuo YH; Lin YW
    J Pharmacol Exp Ther; 2011 Jul; 338(1):184-94. PubMed ID: 21444628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p31comet Induces cellular senescence through p21 accumulation and Mad2 disruption.
    Yun M; Han YH; Yoon SH; Kim HY; Kim BY; Ju YJ; Kang CM; Jang SH; Chung HY; Lee SJ; Cho MH; Yoon G; Park GH; Kim SH; Lee KH
    Mol Cancer Res; 2009 Mar; 7(3):371-82. PubMed ID: 19276188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of mitotic cell death induced by chemotherapy-mediated G2 checkpoint abrogation.
    Vogel C; Hager C; Bastians H
    Cancer Res; 2007 Jan; 67(1):339-45. PubMed ID: 17210716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A high nuclear basal level of ERK2 phosphorylation contributes to the resistance of cisplatin-resistant human ovarian cancer cells.
    Lee S; Yoon S; Kim DH
    Gynecol Oncol; 2007 Feb; 104(2):338-44. PubMed ID: 17023032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NO donor and MEK inhibitor synergistically inhibit proliferation and invasion of cancer cells.
    Furuhashi S; Sugita H; Takamori H; Horino K; Nakahara O; Okabe H; Miyake K; Tanaka H; Beppu T; Baba H
    Int J Oncol; 2012 Mar; 40(3):807-15. PubMed ID: 22025280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and function of the vitamin D receptor in malignant germ cell tumour of the testis.
    Bremmer F; Thelen P; Pottek T; Behnes CL; Radzun HJ; Schweyer S
    Anticancer Res; 2012 Jan; 32(1):341-9. PubMed ID: 22213325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.